Clinical Trials - AGA Medical Corporation

As the leader in the manufacture of devices for minimally invasive repair of structural heart defect, AGA Medical is performing clinical trials in the United States, Europe, United Kingdom and Canada to evaluate potential treatments for a variety of diagnoses and heart defects.

Completed trials have resulted in the availability of important life-changing clinical options for a wider range of heart defects, with over 200,000 occlusion devices manufactured and shipped to physicians and their patients worldwide.

Current Clinical Trials

	Respect Trial - United States AMPLATZER® PFO Occluder - Notice of Availability - Caution: Investigational device. Limited by Federal (U.S.) law to investigational use.
	Premium Trial - United States AMPLATZER® PFO Occluder - Notice of Availability - Caution: Investigational device. Limited by Federal (U.S.) law to investigational use.
	Prima Trial – Europe and Canada AMPLATZER® PFO Occluder - Notice of Availability: Contact AGA Medical for more information on Prima Trial approvals for each country.